Author: Healio ophthalmology

BLOG: The value of educational meetings

I’ve just returned from the Hawaiian Eye meeting, an 18-hour door-to-door trek. As I unpack and organize for tomorrow’s return to ordinary work, still bleary, I ask myself, “Was the trip worth it?” For the third year in a row, the answer is, “Yes!”At Hawaiian Eye, the intimate size (less than a tenth the size of the American Academy of Ophthalmology meeting) and proximity of the physician, administrative and allied health lecture halls encourage a blending of attendees that is not present at larger meetings.

BLOG: Let the sun shine down – CMS releases final reporting requirements for manufacturers and GPOs

On Feb. 1, 2013, the Centers for Medicare and Medicaid Services (CMS) issued its long-awaited final rule regarding the implementation of the physician payment sunshine provisions of the Affordable Care Act. The final rule does not create any new prohibitions on payments to physicians and teaching hospitals, but rather sets out new dates and requirements for manufacturers and other entities to collect data about their payments to physicians and other “covered recipients” and submit that information to CMS. Applicable manufacturers and group purchasing organizations (GPOs) must begin to collect this (Read more...)

BLOG: Raising your awareness of your interactions with lay staff

Doctors often ask me, “How tough should I be with my staff?” Consider America’s marsupial, the humble opossum. Biologists know that “playing possum” is not some coy act. The animals actually pass out from sheer terror. Do your staff members look similarly dazed when you approach them? Or, at the other end of the spectrum, are you ophthalmology’s Rodney Dangerfield, so meek that you get no respect?

CMS issues final rule on Physician Payment Sunshine Act

CMS recently announced in a press release its final rule on the National Physician Payment Transparency Program: Open Payments, also known as the Sunshine Act, aimed to increase transparency among physicians, drug and device manufacturers and health care providers. As part of the Affordable Care Act, the rule calls for manufacturers of drugs, devices, biologics and medical supplies reimbursed by Medicare, Medicaid or Children’s Health Insurance Program to disclose payments made to doctors and teaching hospitals to CMS. According to the release, these manufacturers and group purchasing organizations must also (Read more...)

CMS issues final rule on Physician Payment Sunshine Act

CMS recently announced in a press release its final rule on the National Physician Payment Transparency Program: Open Payments, also known as the Sunshine Act, aimed to increase transparency among physicians, drug and device manufacturers and health care providers. As part of the Affordable Care Act, the rule calls for manufacturers of drugs, devices, biologics and medical supplies reimbursed by Medicare, Medicaid or Children’s Health Insurance Program to disclose payments made to doctors and teaching hospitals to CMS. According to the release, these manufacturers and group purchasing organizations must also (Read more...)

Speaker: Near future holds promise for treating patients with glaucoma

SAN FRANCISCO — With research advances being made in underlying pathogenesis, diagnosis, microincision devices, medications and medication-delivery vehicles, 2013 holds great promise for treating patients with glaucoma, according to a speaker here. Louis B. Cantor, MD, in the keynote address at the New Horizons Forum during the Glaucoma 360 meeting, asked the question, “Is ’13 our lucky number?”